Pramipexole di-HCl
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Pramipexole di-HCl
Modification SPE2D220D0091 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Modification SPE2D220D0091 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract.
Modification P00004 SPE2D220D0091 issued to Invoke Option 3 effective April 29, 2023 through April 28, 2024.
Modification P00003 SPE2D220D0091 issued to Invoke Option 2 effective April 29, 2022 through April 28, 2023.
Modification P00002 SPE2D220D0091 issued to Invoke Option 1 effective April 29, 2021 through April 28, 2022.
Modification P00001 SPE2D220D0091 to incorporate FAR 52.204-24 and FAR 52.205-25 into contract.
Amendment 0006 SPE2D2-19-R-0051 Pramipexole di-HCl to extend the closing date to December 31, 2019 at 3:00 PM EST. To correct page 4 of solicaiiton block 9; titled, Submisssion Instructions for "hand carried" offers building number. To corect pages 29-30 for the "Statement of Work" of solicitation. To incorporate FAR Clause 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment into the solicitation.